Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

International pilot external quality assessment scheme for analysis and reporting of circulating tumour DNA.

BMC cancer - 9 Aug 2018

Keppens Cleo, Dequeker Elisabeth M C, Patton Simon J, Normanno Nicola, Fenizia Francesca, Butler Rachel, Cheetham Melanie, Fairley Jennifer A, Williams Hannah, Hall Jacqueline A, Schuuring Ed, Deans Zandra C

Abstract excerpt

BACKGROUND: Molecular analysis of circulating tumour DNA (ctDNA) is becoming increasingly important in clinical treatment decisions. A pilot External Quality Assessment (EQA) scheme for ctDNA analysis was organized by four European EQA providers under the umbrella organization IQN Path, in order to investigate the feasibility of delivering an EQA to assess the detection of clinically relevant variants in plasma...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cell-Free Nucleic Acids
Share to Circulating Tumor DNA

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to ErbB Receptors

Share to NRAS gene

Share to Mutation

Share to Neoplasms

Share to Proto-Oncogene Proteins p21(ras)

Share to Quality Assurance, Health Care

Source

Open in PubMed Open full text

Identifiers

PMID: 30092778
DOI: 10.1186/s12885-018-4694-x
PMCID: PMC6085634

Genes

EGFR
KRAS
NRAS

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

International pilot external quality assessment scheme for analysis and reporting of circulating tumour DNA.PMID 30092778Read ↗

Results of a worldwide External Quality Assessment of cfDNA testing in Lung CancerSemantic proximity Read ↗

Results of a worldwide external quality assessment of cfDNA testing in lung Cancer.Semantic proximity Read ↗

Implementation of circulating tumour DNA multi-target mutation testing in plasma: a perspective from an external quality assessment providers' survey.Semantic proximity Read ↗

External Quality Assessment on Molecular Tumor Profiling with Circulating Tumor DNA-Based Methodologies Routinely Used in Clinical Pathology within the COIN Consortium.Semantic proximity Read ↗

Evaluation of ctDNA-based ESR1 testing in breast cancer: results from the first external quality assessment scheme in China.Semantic proximity Read ↗

Results from an IFCC global survey on laboratory practices for the analysis of circulating tumor DNA.Semantic proximity Read ↗

Assessing standardization of molecular testing for non-small-cell lung cancer: results of a worldwide external quality assessment (EQA) scheme for EGFR mutation testing.Semantic proximity Read ↗

What's in a Name? A Coordinated Approach toward the Correct Use of a Uniform Nomenclature to Improve Patient Reports and Databases.Semantic proximity Read ↗

Improvement in the quality of molecular analysis of EGFR in non-small-cell lung cancer detected by three rounds of external quality assessment.Semantic proximity Read ↗

External quality assessment for mutation detection in the BRCA1 and BRCA2 genes: EMQN's experience of 3 years.Semantic proximity Read ↗

Results of the UK NEQAS for Molecular Genetics reference sample analysis.Semantic proximity Read ↗

The Italian external quality assessment for RAS testing in colorectal carcinoma identifies methods-related inter-laboratory differences.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.